Erba Diagnostics (ERB) Post Breakeven Q3 on 83% Jump in Revenue
Tweet Send to a Friend
Erba Diagnostics (NYSE: ERB) reported Q3 EPS of $0.00, versus ($0.01) reported last year. Revenue for the quarter came rose ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
